GT’s cover story last June profiled First Genetic Trust and its plan to profit from developing secure genomic databases. It first intended to make money by supporting research at pharma and biomed centers. To that end, FGT and GlaxoSmithKline started a SNP-based research collaboration in October. In April, FGT entered a genotype/phenotype association-based research collaboration with Johns Hopkins University.